SNPHY - Santen Pharmaceutical Co. Ltd. GAAP EPS of ¥69.68 revenue of ¥145.81B November, 07 2023 11:11 AM Santen Pharmaceutical Co. Ltd. ADR 2023-11-07 11:11:37 ET More on Santen Pharmaceutical Co., Ltd. Historical earnings data for Santen Pharmaceutical Co., Ltd. Financial information for Santen Pharmaceutical Co., Ltd. For further details see: Santen Pharmaceutical Co., Ltd. GAAP EPS of ¥69.68, revenue of ¥145.81B